KeriFlex MCP and PIP Finger Joint Prostheses
Keri Medical SA · Decision date Oct 29, 2026
What did the FDA decide?
FDA recorded a decision of SESE for K263582, a 510(k) premarket notification submitted by Keri Medical SA of Plan-Les-Ouates, Switzerland, covering the KeriFlex® MCP and PIP Finger Joint Prostheses. The decision date is 2026-10-29; the same record lists a receipt date of 09/30/2026, product code KYJ, and orthopedic review panel. In 510(k) terms, SESE denotes a cleared premarket notification rather than a PMA approval.
The record identifies the device as a finger joint prosthesis line spanning metacarpophalangeal and proximal interphalangeal applications, but the available data do not describe materials, fixation, sizes, or indications for use. The listed summary designation indicates a 510(k) summary exists, yet its contents are not included here. No predicate device, substantial-equivalence basis, or clinical data are available, so the scope of the clearance beyond the named device family remains unknown.
Industry researchers should treat this as a dated clearance record only. The public page already displays the original FDA fields; any labeling, patient-selection, or performance details would need to be read from the underlying FDA documents rather than inferred from this entry.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Orthopedic
- Decision date
- Oct 29, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K263582
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Keri Medical SA
- Product code
- KYJ
- Decision code
- SESE
- Decision date
- Oct 29, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Prosthesis, Finger, Constrained, Polymer.
- Applicant
- Keri Medical SA
- Product code
- KYJ
- FDA device class
- 2
FDA decision timeline
K263582 received
Application receipt date recorded by FDA.
K263582 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Keri Medical SA
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Plan-Les-Ouates
Sources and methodology
- Original FDA record: K263582
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records